entity

alpha-synuclein oligomers

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about alpha-synuclein oligomers: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

13Connections
0Hypotheses
2Analyses
9Outgoing
4Incoming
0Experiments
3Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Alpha-Synuclein Oligomers - Biomarker

biomarker · 1478 words

Outgoing (9)

TargetRelationTypeStr
membrane permeabilizationcausesmechanism0.90
neurotoxicitycausesphenotype0.90
Intracellular Aggregationmediatesprocess0.90
Microglia Activationupregulatesprocess0.85
Astrocytesassociated_withcell_type0.80

Incoming (4)

SourceRelationTypeStr
Glucosylceramideenhancesdrug0.90
glucosylceramidestabilizesmetabolite0.90
biomarkers-alpha-synuclein-oligomersdescribeswiki0.90
ASyn295 antibodytargetsdrug0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.571

GBA-Synuclein Loop Therapeutics for PD

neurodegeneration | 2026-04-01 | 1 hypotheses Top: 0.525

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (3)

Multi-agent debates referencing this entity

Can computational de novo protein binder design produce stable binders that bloc

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Can computationally designed binders against alpha-synuclein realistically trans

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

How to break the GBA-alpha-synuclein bidirectional loop for Parkinson's Disease

closed · Rounds: 4 · Score: 0.90 · 2026-04-06

Related Research

Hypotheses and analyses mentioning alpha-synuclein oligomers in their description or question text

No additional research found